vs
Side-by-side financial comparison of Maison Solutions Inc. (MSS) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $20.6M, roughly 1.3× Entrada Therapeutics, Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -84.4%, a 66.4% gap on every dollar of revenue. On growth, Maison Solutions Inc. posted the faster year-over-year revenue change (-10.9% vs -65.2%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 6.4%).
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
MSS vs TRDA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $27.6M | $20.6M |
| Net Profit | $-5.0M | $-17.3M |
| Gross Margin | 23.4% | — |
| Operating Margin | -4.9% | -106.0% |
| Net Margin | -18.0% | -84.4% |
| Revenue YoY | -10.9% | -65.2% |
| Net Profit YoY | -1840.5% | -173.8% |
| EPS (diluted) | $-0.23 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.6M | — | ||
| Q3 25 | $27.2M | — | ||
| Q2 25 | $34.4M | — | ||
| Q1 25 | $32.3M | $20.6M | ||
| Q4 24 | $29.4M | $37.4M | ||
| Q3 24 | $28.2M | $19.6M | ||
| Q2 24 | $16.9M | $94.7M | ||
| Q1 24 | $13.6M | $59.1M |
| Q4 25 | $-5.0M | — | ||
| Q3 25 | $-1.5M | — | ||
| Q2 25 | $-287.4K | — | ||
| Q1 25 | $1.0M | $-17.3M | ||
| Q4 24 | $-256.0K | $1.1M | ||
| Q3 24 | $700.9K | $-14.0M | ||
| Q2 24 | $-2.8M | $55.0M | ||
| Q1 24 | $-549.0K | $23.5M |
| Q4 25 | 23.4% | — | ||
| Q3 25 | 24.1% | — | ||
| Q2 25 | 9.5% | — | ||
| Q1 25 | 21.8% | — | ||
| Q4 24 | 26.9% | — | ||
| Q3 24 | 28.9% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | 23.4% | — |
| Q4 25 | -4.9% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | -15.9% | — | ||
| Q1 25 | 3.7% | -106.0% | ||
| Q4 24 | 3.2% | -15.7% | ||
| Q3 24 | 7.3% | -110.7% | ||
| Q2 24 | -14.4% | 56.4% | ||
| Q1 24 | -2.3% | 35.7% |
| Q4 25 | -18.0% | — | ||
| Q3 25 | -5.7% | — | ||
| Q2 25 | -0.8% | — | ||
| Q1 25 | 3.1% | -84.4% | ||
| Q4 24 | -0.9% | 3.0% | ||
| Q3 24 | 2.5% | -71.7% | ||
| Q2 24 | -16.4% | 58.1% | ||
| Q1 24 | -4.0% | 39.7% |
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $-0.08 | — | ||
| Q2 25 | $-0.02 | — | ||
| Q1 25 | $0.06 | $-0.42 | ||
| Q4 24 | $-0.01 | $-0.20 | ||
| Q3 24 | $0.04 | $-0.35 | ||
| Q2 24 | $-0.16 | $1.55 | ||
| Q1 24 | $-0.03 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $67.8M |
| Total DebtLower is stronger | $2.6M | — |
| Stockholders' EquityBook value | $11.6M | $417.3M |
| Total Assets | $75.4M | $486.5M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $775.4K | — | ||
| Q1 25 | $445.4K | $67.8M | ||
| Q4 24 | $355.7K | $101.2M | ||
| Q3 24 | $588.9K | $78.0M | ||
| Q2 24 | $2.1M | $185.3M | ||
| Q1 24 | $9.4M | $68.4M |
| Q4 25 | $2.6M | — | ||
| Q3 25 | $2.6M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $2.6M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $10.1M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $12.0M | $417.3M | ||
| Q4 24 | $10.9M | $428.7M | ||
| Q3 24 | $11.2M | $422.4M | ||
| Q2 24 | $10.5M | $429.9M | ||
| Q1 24 | $13.3M | $269.4M |
| Q4 25 | $75.4M | — | ||
| Q3 25 | $73.3M | — | ||
| Q2 25 | $77.4M | — | ||
| Q1 25 | $82.7M | $486.5M | ||
| Q4 24 | $82.7M | $526.3M | ||
| Q3 24 | $82.1M | $554.6M | ||
| Q2 24 | $82.4M | $582.0M | ||
| Q1 24 | $44.2M | $510.8M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.23× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.7M | $-38.5M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -192.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $1.1M | — | ||
| Q2 25 | $-1.6M | — | ||
| Q1 25 | $1.7M | $-38.5M | ||
| Q4 24 | $1.1M | $-31.6M | ||
| Q3 24 | $3.6M | $-24.3M | ||
| Q2 24 | $-2.6M | $39.8M | ||
| Q1 24 | $-1.4M | $-25.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.66× | — | ||
| Q4 24 | — | -27.94× | ||
| Q3 24 | 5.12× | — | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
TRDA
Segment breakdown not available.
